Bayesian Designs for Phase I-II Clinical Trials

Bayesian Designs for Phase I-II Clinical Trials
Author :
Publisher : Chapman & Hall/CRC
Total Pages : 0
Release :
ISBN-10 : 1498709559
ISBN-13 : 9781498709552
Rating : 4/5 (552 Downloads)

Book Synopsis Bayesian Designs for Phase I-II Clinical Trials by : Ying Yuan

Download or read book Bayesian Designs for Phase I-II Clinical Trials written by Ying Yuan and published by Chapman & Hall/CRC. This book was released on 2015-12-22 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: Chapter 14: Optimizing Sedative Dose in Preterm Infants -- Bibliography -- Back Cover

Bayesian Designs for Phase I-II Clinical Trials Related Books

Bayesian Designs for Phase I-II Clinical Trials
Language: en
Pages: 0
Authors: Ying Yuan
Categories: Bayesian statistical decision theory
Type: BOOK - Published: 2015-12-22 - Publisher: Chapman & Hall/CRC

GET EBOOK

Chapter 14: Optimizing Sedative Dose in Preterm Infants -- Bibliography -- Back Cover
Bayesian Adaptive Methods for Clinical Trials
Language: en
Pages: 316
Authors: Scott M. Berry
Categories: Mathematics
Type: BOOK - Published: 2010-07-19 - Publisher: CRC Press

GET EBOOK

Already popular in the analysis of medical device trials, adaptive Bayesian designs are increasingly being used in drug development for a wide variety of diseas
Clinical Trial Design
Language: en
Pages: 368
Authors: Guosheng Yin
Categories: Medical
Type: BOOK - Published: 2013-06-07 - Publisher: John Wiley & Sons

GET EBOOK

A balanced treatment of the theories, methodologies, and design issues involved in clinical trials using statistical methods There has been enormous interest an
Bayesian Adaptive Designs in Phase I/II Clinical Trials
Language: en
Pages: 80
Authors: Wei Zhong
Categories:
Type: BOOK - Published: 2012 - Publisher:

GET EBOOK

Phase I Oncology Drug Development
Language: en
Pages: 352
Authors: Timothy A. Yap
Categories: Medical
Type: BOOK - Published: 2020-09-16 - Publisher: Springer Nature

GET EBOOK

This book provides a detailed review of how oncology drug development has changed over the past decade, and serves as a comprehensive guide for the practicaliti